Skip to main content

Caroline Catherman

Caroline joined Healthcare Brew in July 2024 after three years as a health reporter for the Orlando Sentinel. Her work has appeared in outlets including CNN, Science Magazine, and The Chicago Tribune. She holds a master’s in health, environment, and science journalism from Northwestern University and degrees in psychology and English from Emory University, where she was first author on a public health study. Get in touch: [email protected]

Health symbol with stars flickering
Payers

What does a star system makeover mean for Medicare Advantage?

One researcher says the changes do not fix fundamental problems with the system.

A Black woman gets a prenatal visit
Payers

Startups are getting in on the growing doula industry

Payers, providers, and women’s health companies hope doulas can reduce maternal mortality.

A measuring tape wrapping around a large-scaled pill.
Pharma

How Eli Lilly’s oral GLP-1 could change the obesity drug market

A hot new GLP-1 bombshell has entered the villa.

Headshot of Scale AI's MaryAnne Rizk
Tech

Scale AI leader on why clinical AI needs a ‘trust layer’

Responsibly scaling AI is a big job.

Mashup of hospital symbol, stethoscope, IV bag, oxygen tank, and other medical devices on orange background
Tech

Recall Roundup: March 2026

March included recalls associated with ventilators and heart pump controllers.

Healthcare Brew's August on Rotation editorial feature
Direct Care

On Rotation: March 2026

The latest and biggest healthcare executive moves.

Headshot of Viveca Livezey, a woman with long dark brown hair smiling at the camera.
Tech

Click Therapeutics leader talks digital treatments, dangers of unlimited AI

A convo with Viveca Livezey, Click’s SVP of clinical development and evidence generation.

Novo Nordisk will ask for FDA approval on a semaglutide pill for weight loss
Pharma

Despite FDA crackdown, unapproved GLP-1s still threaten the industry

Legitimate compounders are threatened by false advertising of counterfeit GLP-1s, legal experts warn.

Headshot of a man with short brown hair, wearing a striped blazer and white button down shirt.
Payers

Curative CEO Fred Turner explains why his alternative health plan is valued at $1.3b

The Covid test-provider-turned-insurer touts $0 copays, deductibles, and coinsurance for members who get preventative care.

crispr illustration
Pharma

Could relaxed regulations boost gene therapy for ultra-rare diseases?

Companies like Prime Medicine and Aurora Therapeutics are shooting their shot.